@stales Yes! They are too transactional in the sense that patient gets de-identified with a number at the start and often forgotten at the end. We need better long-term partnerships to solve these complex medical challenges.
I want to give a big shout out to the Patient Cloud team and all of the patients we are working with to make myMedidata the right tool for an industry that is literally reinventing itself around decentralized research. https://t.co/i6cvzuO8AJ
.@Captainclinical is taking over our @Medidata channel this Thursday to discuss his latest book #Thepatientequation and how #COVID19 is changing the healthcare system. Visit to find out more details here: https://t.co/gCcrAlgwgK and join our conversation using #CTSM#Twitterchat
.@findajc Anthony Costello has spent his career as an entrepreneur, visionary and a leader to move technology forward in the world of #clinicaltrials. Today, he join the #pinksocks tribe in what I consider to be long overdue. Find the good in what you do, and keep doing it.
#news: Our @findajc sat down with @OutsourcPharma to discuss our collaboration with @ICONplc Mapi Research Trust to build a global library of pre-configured + pre-approved eCOA questionnaires to accelerate study start-up. Read more here: https://t.co/yl7yw8rZzd
#ClinicalTrials
We're thrilled to announce that our @stales is a finalist in the Patient Champion Award: Patient Advocate category for @efp_awards 2019. Congrats to all other finalists and good luck! 🎉
https://t.co/iLTUXjZ9rM
#efpawards#pharma#awards
“From a young age, we learn to share, but when it comes to the collection and management of clinical research data, the opposite is true.” Read the article by our own @findajc, our VP of Mobile Health in @PharmaVoice here: https://t.co/2XIMv4PsSN
#ClinicalTrials
Thanks Daphne. We tried to share and publish everything possible from REMOTE. Many entrepreneurs and innovators persevered to reach this point of industry uptake — a good signal to improve access to research. https://t.co/AWjVWN3rNR
Prediction: In 3 yr, #clinicaltrials will be in a bimodal distribution from 100% virtual to 100% in clinic. Some TAs: 80%, others 20%. https://t.co/xwUUCBJxeh